Susan Mesco | Pacira Pharmaceuticals, Inc. |
David M. Stack | Pacira Pharmaceuticals, Inc. |
Richard E. Scranton | Pacira Pharmaceuticals, Inc. |
Charles A. Reinhart III | Pacira Pharmaceuticals, Inc. |
Randall S. Stanicky | RBC Capital Markets LLC |
David A. Amsellem | Piper Jaffray & Co. |
David Michael Steinberg | Jefferies LLC |
Dana Flanders | Goldman Sachs & Co. LLC |
Serge Belanger | Needham & Co. LLC |
Ami Fadia | Leerink Partners LLC |
Gary Nachman | BMO Capital Markets (United States) |
Boris Peaker | Cowen & Co. LLC |
Good day, ladies and gentlemen and welcome to the Third Quarter 2018 Pacira Pharmaceuticals Incorporated Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this call is being recorded. I would now like to introduce your host for today's conference, Susan Mesco, Head of Investor Relations.